Literature DB >> 15129812

Graves' ophthalmopathy and atrophic thyroiditis: a case report.

G Tamagno1, E De Carlo, C Betterle, G Murialdo.   

Abstract

Graves' ophthalmopathy (GO)--also known as thyroid-associated orbitopathy or ophthalmopathy--usually affects patients with Graves' disease. Antibodies stimulating the TSH receptor are thought to be involved in the pathogenesis of this important and disabling extra-thyroidal manifestation of Graves' disease. Less frequently, GO occurs in subjects who neither have nor have ever shown evidence of thyroid dysfunction ("euthyroid GO"), while the occurrence of GO in patients with autoimmune Hashimoto's thyroiditis is thought to be quite rare and has sporadically been reported. The late and abrupt occurrence of severe GO without hyperthyroidism in an 88-yr-old woman with primary myxedema due to atrophic thyroiditis must be considered as an exceptional event. In this patient, GO was combined with elevated titres of serum auto-antibodies directed against the TSH receptor, while serum levels of anti-thyroglobulin and thyroperoxidase antibodies were within the normal range or only occasionally slightly above the normal values.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15129812     DOI: 10.1007/BF03346262

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  27 in total

Review 1.  Anti-TSH receptor antibodies in clinical practice.

Authors:  J Orgiazzi
Journal:  Endocrinol Metab Clin North Am       Date:  2000-06       Impact factor: 4.741

Review 2.  The thyrotropin receptor in thyroid diseases.

Authors:  R Paschke; M Ludgate
Journal:  N Engl J Med       Date:  1997-12-04       Impact factor: 91.245

Review 3.  The genetics of Hashimoto's disease.

Authors:  G Barbesino; L Chiovato
Journal:  Endocrinol Metab Clin North Am       Date:  2000-06       Impact factor: 4.741

Review 4.  Management of Graves' ophthalmopathy: reality and perspectives.

Authors:  L Bartalena; A Pinchera; C Marcocci
Journal:  Endocr Rev       Date:  2000-04       Impact factor: 19.871

5.  Thyrotropin receptor expression in Graves' orbital adipose/connective tissues: potential autoantigen in Graves' ophthalmopathy.

Authors:  R S Bahn; C M Dutton; N Natt; W Joba; C Spitzweg; A E Heufelder
Journal:  J Clin Endocrinol Metab       Date:  1998-03       Impact factor: 5.958

Review 6.  Pathogenesis of ophthalmopathy in autoimmune thyroid disease.

Authors:  A E Heufelder
Journal:  Rev Endocr Metab Disord       Date:  2000-01       Impact factor: 6.514

7.  Hypothyroid Graves' disease.

Authors:  J H Christy; R S Morse
Journal:  Am J Med       Date:  1977-02       Impact factor: 4.965

8.  High prevalence and little change in TSH receptor blocking antibody titres with thyroxine and antithyroid drug therapy in patients with non-goitrous autoimmune thyroiditis.

Authors:  B Y Cho; W B Kim; J H Chung; K H Yi; Y K Shong; H K Lee; C S Koh
Journal:  Clin Endocrinol (Oxf)       Date:  1995-10       Impact factor: 3.478

9.  Goitrous hypothyroidism with blocking or stimulating thyrotropin binding inhibitor immunoglobulins.

Authors:  K Sato; K Okamura; M Yoshinari; H Ikenoue; T Kuroda; M Torisu; M Fujishima
Journal:  J Clin Endocrinol Metab       Date:  1990-10       Impact factor: 5.958

10.  Pathogenesis of thyroid-associated ophthalmopathy: an autoimmune disorder of the eye muscle associated with Graves' hyperthyroidism and Hashimoto's thyroiditis.

Authors:  J R Wall; N Bernard; A Boucher; M Salvi; Z G Zhang; J Kennerdell; A Tyutyunikov; C Genovese
Journal:  Clin Immunol Immunopathol       Date:  1993-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.